Delivery Order SPE2DB20D3101-SPE2DB25FRTU9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Briviact 10 mg/mL oral solution in a 300 mL quantity, with a ceiling value of $2,116.72. This competitively awarded, firm fixed-price delivery order is set to be completed by August 13, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,138.04 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Briviact 10 mg/mL oral solution in a 300 mL quantity. This is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a $7,234.61 delivery order to AmerisourceBergen Drug Corp for Briviact 10 mg/ml oral solution (300ml) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price contract represents a competitively awarded, non-set-aside delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and running through December 2026. The...
- The Defense Logistics Agency awarded a $10,974.69 delivery order to AmerisourceBergen Drug Corp for Briviact 100 mg tablets (60-count units) under a firm fixed price contract. The award was made on August 1, 2025, with an ultimate completion date of August 4, 2025, and represents a non-competitive, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same municipality. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Briviact 100 mg tablets (60-count) under a firm fixed-price contract with a ceiling value of $11,044.73. This non-set-aside competitive award is scheduled for completion by August 25, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Briviact 100 mg tablets (60-count packages) with a ceiling value of $1,067.55. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation, and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,072.23 for Briviact 100 mg tablets (60-count) with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and reflects AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical procurement system. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $19,116.30 to AmerisourceBergen Drug Corp for the supply of Briviact 10 mg/mL oral solution in 300 mL quantities. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 6, 2025, and was awarded on August 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $5,677.12 to AmerisourceBergen Drug Corp for the supply of Briviact 100 mg tablets (60-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitive, non-set-aside award employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a $8,376.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Briviact 25 mg tablets (60-count units) on August 1, 2025, with an ultimate completion date of August 4, 2025. The contract is unclassified as a set-aside and represents a small-value transaction typical of the company's extensive pharmaceutical supply work with DLA. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRTU9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,601.40 to AmerisourceBergen Drug Corp for Briviact 10 mg/mL oral solution (300mL) on August 28, 2025, with completion due by August 29, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.9 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceuticals and medical commodities to military healthcare systems worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. The company's contract awards with the Defense Logistics Agency demonstrate consistent capability to meet federal procurement requirements across multiple therapeutic domains, with delivery orders ranging from small-value transactions to substantial orders exceeding $45,000. This award of Briviact, an antipsychotic medication, reflects the company's role in supporting military healthcare operations through flexible and comprehensive contract vehicles designed to provide pharmaceutical access across the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 8/28/25 |